Long non-coding RNA COX7C-5 promotes hepatocellular carcinoma progression via miR-581/ZEB2 axis

被引:6
作者
Lin, Yantin [1 ,3 ]
Wang, Fei [2 ]
Zhong, Yue [2 ]
Cheng, Niang Mei [2 ]
Xiong, Jiahui [1 ]
Zheng, Xiaoyuan [2 ]
Zhou, Yang [2 ]
Gao, Shaodong [1 ,3 ]
Li, Fang [1 ,3 ]
Wang, Yingchao [2 ]
Yang, Xiaoyu [1 ,3 ]
Zhao, Bixing [2 ]
机构
[1] Fujian Univ Tradit Chinese Med, Fuzhou Hosp Tradit Chinese Med, Fuzhou 350001, Peoples R China
[2] Fujian Med Univ, United Innovat Meng Chao Hepatobiliary Technol Key, Meng chao Hepatobiliary Hosp, Fuzhou 350025, Peoples R China
[3] Fujian Med Univ, Sch Basic Med Sci, Fuzhou 350122, Peoples R China
基金
中国国家自然科学基金;
关键词
Lnc-COX7C-5; microRNA-581; ZEB2; Hepatocellular carcinoma; EPITHELIAL-MESENCHYMAL TRANSITION; PROLIFERATION; METASTASIS; ZEB2; TARGETS;
D O I
10.1016/j.cellsig.2022.110501
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Long non-coding RNAs (lncRNA) play crucial roles in hepatocellular carcinoma (HCC) progression. However, the functional roles of lncRNAs in HCC still remain largely unknown. Our study aimed to investigate the biological function and potential molecular mechanism of lnc-COX7C-5 in HCC. Here, we show that Lnc-COX7C-5 was significantly upregulated in HCC tissues, which was correlated with poor prognosis in HCC patients. Lnc-COX7C-5 positively regulated proliferation, migration, and invasion of HCC cells. Mechanistically, lnc-COX7C-5 function as a competing endogenous RNA (ceRNA) for miR-581 in HCC cells. Over-expression or knockdown of miR-581 could alter cell phenotypes caused by Lnc-COX7C-5 in HCC. Further investigations indicated that ZEB2 was demonstrated as a downstream target of miR-581. In mouse model, over-expression of Lnc-COX7C-5 facilitate lung metastasis of HCC. Collectively, Lnc-COX7C-5 promote HCC tumorigenesis and progression by targeting the miR-581/ZEB2 axis. Lnc-COX7C-5 may be a potential therapeutic target for HCC.
引用
收藏
页数:10
相关论文
共 37 条
[1]   Non-coding RNA networks in cancer [J].
Anastasiadou, Eleni ;
Jacob, Leni S. ;
Slack, Frank J. .
NATURE REVIEWS CANCER, 2018, 18 (01) :5-18
[2]  
Bray F, 2018, CA-CANCER J CLIN, V68, P394, DOI [10.3322/caac.21492, 10.3322/caac.21609]
[3]   MiRNA-206 inhibits proliferation of renal clear cell carcinoma by targeting ZEB2 [J].
Chen, X-F ;
Guo, J-F ;
Xu, J-F ;
Yin, S-H ;
Cao, W-L .
EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2019, 23 (18) :7826-7834
[4]   ZEB2 Promotes the Metastasis of Gastric Cancer and Modulates Epithelial Mesenchymal Transition of Gastric Cancer Cells [J].
Dai, Ying-Huan ;
Tang, Ya-Ping ;
Zhu, Hong-Yi ;
Lv, Liang ;
Chu, Yi ;
Zhou, Yu-Qian ;
Huo, Ji-Rong .
DIGESTIVE DISEASES AND SCIENCES, 2012, 57 (05) :1253-1260
[5]   New insights into the mechanisms of epithelial-mesenchymal transition and implications for cancer [J].
Dongre, Anushka ;
Weinberg, Robert A. .
NATURE REVIEWS MOLECULAR CELL BIOLOGY, 2019, 20 (02) :69-84
[6]   Trends in liver cancer mortality in the United States: Dual burden among foreign- and US-born persons [J].
Endeshaw, Meheret ;
Hallowell, Benjamin D. ;
Razzaghi, Hilda ;
Senkomago, Virginia ;
McKenna, Matthew T. ;
Saraiya, Mona .
CANCER, 2019, 125 (05) :726-734
[7]   The crucial role of ZEB2: From development to epithelial-to-mesenchymal transition and cancer complexity [J].
Fardi, Masoumeh ;
Alivand, Mohammadreza ;
Baradaran, Behzad ;
Hagh, Majid Farshdousti ;
Solali, Saeed .
JOURNAL OF CELLULAR PHYSIOLOGY, 2019, 234 (09) :14783-14799
[8]   LncRNA-CTS promotes metastasis and epithelial-to-mesenchymal transition through regulating miR-505/ZEB2 axis in cervical cancer [J].
Feng, Shujun ;
Liu, Wei ;
Bai, Xiaoxu ;
Pan, Wenjing ;
Jia, Zhaoyang ;
Zhang, Shunjin ;
Zhu, Yimin ;
Tan, Wenhua .
CANCER LETTERS, 2019, 465 :105-117
[9]   Cancer statistics for the year 2020: An overview [J].
Ferlay, Jacques ;
Colombet, Murielle ;
Soerjomataram, Isabelle ;
Parkin, Donald M. ;
Pineros, Marion ;
Znaor, Ariana ;
Bray, Freddie .
INTERNATIONAL JOURNAL OF CANCER, 2021, 149 (04) :778-789
[10]  
Gao HB, 2019, EUR REV MED PHARMACO, V23, P5149, DOI 10.26355/eurrev_201906_18179